DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same

Abstract

The present invention is directed to protocells for specific targeting of hepatocellular and other cancer cells which comprise a nanoporous silica core with a supported lipid bilayer; at least one agent which facilitates cancer cell death (such as a traditional small molecule, a macromolecular cargo (e.g. siRNA or a protein toxin such as ricin toxin A-chain or diphtheria toxin A-chain) and/or a histone-packaged plasmid DNA disposed within the nanoporous silica core (preferably supercoiled in order to more efficiently package the DNA into protocells) which is optionally modified with a nuclear localization sequence to assist in localizing protocells within the nucleus of the cancer cell and the ability to express peptides involved in therapy (apoptosis/cell death) of the cancer cell or as a reporter, a targeting peptide which targets cancer cells in tissue to be treated such that binding of the protocell to the targeted cells is specific and enhanced and a fusogenic peptide that promotes endosomal escape of protocells and encapsulated DNA. Protocells according to the present invention may be used to treat cancer, especially including hepatocellular (liver) cancer using novel binding peptides (c-MET peptides) which selectively bind to hepatocellular tissue or to function in diagnosis of cancer, including cancermore » treatment and drug discovery.

Inventors:
; ; ;
Issue Date:
Research Org.:
Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1345394
Patent Number(s):
9579283
Application Number:
14/113,371
Assignee:
STC.UNM
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
DOE Contract Number:  
AC04-94AL85000
Resource Type:
Patent
Resource Relation:
Patent File Date: 2012 Apr 27
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Brinker, C. Jeffrey, Carnes, Eric C., Ashley, Carlee Erin, and Willman, Cheryl L. Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same. United States: N. p., 2017. Web.
Brinker, C. Jeffrey, Carnes, Eric C., Ashley, Carlee Erin, & Willman, Cheryl L. Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same. United States.
Brinker, C. Jeffrey, Carnes, Eric C., Ashley, Carlee Erin, and Willman, Cheryl L. Tue . "Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same". United States. https://www.osti.gov/servlets/purl/1345394.
@article{osti_1345394,
title = {Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same},
author = {Brinker, C. Jeffrey and Carnes, Eric C. and Ashley, Carlee Erin and Willman, Cheryl L.},
abstractNote = {The present invention is directed to protocells for specific targeting of hepatocellular and other cancer cells which comprise a nanoporous silica core with a supported lipid bilayer; at least one agent which facilitates cancer cell death (such as a traditional small molecule, a macromolecular cargo (e.g. siRNA or a protein toxin such as ricin toxin A-chain or diphtheria toxin A-chain) and/or a histone-packaged plasmid DNA disposed within the nanoporous silica core (preferably supercoiled in order to more efficiently package the DNA into protocells) which is optionally modified with a nuclear localization sequence to assist in localizing protocells within the nucleus of the cancer cell and the ability to express peptides involved in therapy (apoptosis/cell death) of the cancer cell or as a reporter, a targeting peptide which targets cancer cells in tissue to be treated such that binding of the protocell to the targeted cells is specific and enhanced and a fusogenic peptide that promotes endosomal escape of protocells and encapsulated DNA. Protocells according to the present invention may be used to treat cancer, especially including hepatocellular (liver) cancer using novel binding peptides (c-MET peptides) which selectively bind to hepatocellular tissue or to function in diagnosis of cancer, including cancer treatment and drug discovery.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Feb 28 00:00:00 EST 2017},
month = {Tue Feb 28 00:00:00 EST 2017}
}

Works referenced in this record:

Liposomal delivery system with photoactivatable triggered release
patent, January 1994


Transport vectors
patent, September 2006


Detection systems utilizing supported lipid bilayers
patent, April 2009


Fluorescent silica-based nanoparticles
patent, October 2012


Porous nanoparticle supported lipid bilayer nanostructures
patent, May 2014


Protocells and their use for targeted delivery of multicomponent cargos to cancer cells
patent, March 2015


Layered Nanoparticles
patent-application, April 2008


Lipid bilayers on nanotextured solid surfaces
patent-application, July 2008


Delivery of Nanoparticles and/or Agents to Cells
patent-application, September 2008


Nanostructures Suitable for Sequestering Cholesterol and Other Molecules
patent-application, December 2009


Porous Nanoparticle Supported Lipid Bilayer Nanostructures
patent-application, November 2011


Porous Nanoparticle-Supported Lipid Bilayers (Photocells) for Targeted Delivery and Methods of Using Same
patent-application, March 2014


Porous Nanoparticle Supported Lipid Nanostructures
patent-application, October 2014


CRLF-2 Binding Peptides, Protocells and Viral-Like Particles Useful in the Treatment of Cancer, Including Acute Lymphoblastic Leukemia (All)
patent-application, January 2015


Protocells and Their Use for Targeted Delivery of Multicomponent Cargos to Cancer Cells
patent-application, June 2015


Porous Nanoparticle-Supported Lipid Bilayers (Protocells) for Targeted Delivery and Methods of Using Same
patent-application, April 2016


The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers
journal, April 2011


Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
journal, March 2008


siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo
journal, December 2008


Lymphatic uptake of lipid nanoparticles following endotracheal administration
journal, January 2006


Microparticles with Bimodal Nanoporosity Derived by Microemulsion Templating
journal, December 2009


Cancer nanotechnology: opportunities and challenges
journal, March 2005


Aerosol-assisted self-assembly of mesostructured spherical nanoparticles
journal, March 1999


Neutron Reflectivity Study of Lipid Membranes Assembled on Ordered Nanocomposite and Nanoporous Silica Thin Films
journal, March 2005


Transferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 cases
journal, January 1988


The possible use of RNA interference in diagnosis and treatment of various diseases
journal, September 2009


Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
journal, May 2001


siRNA delivery systems for cancer treatment
journal, August 2009


“HFP” Fluorinated Cationic Lipids for Enhanced Lipoplex Stability and Gene Delivery
journal, February 2010


Pathogenesis of hepatocellular carcinoma and molecular therapies
journal, January 2009


Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
journal, August 2005


Electrostatically Mediated Liposome Fusion and Lipid Exchange with a Nanoparticle-Supported Bilayer for Control of Surface Charge, Drug Containment, and Delivery
journal, June 2009


Porous Nanoparticle Supported Lipid Bilayers (Protocells) as Delivery Vehicles
journal, February 2009


Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient
journal, October 2006


Characterization of 5-fluorouracil loaded liposomes prepared by reverse-phase evaporation or freezing-thawing extrusion methods: study of drug release
journal, December 1993


Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance
journal, February 2001


Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines
journal, January 1995


Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line
journal, May 1999


Organic Functionalization and Morphology Control of Mesoporous Silicas via a Co-Condensation Synthesis Method
journal, November 2003


Molecular Assembly in Ordered Mesoporosity:  A New Class of Highly Functional Nanoscale Materials
journal, September 2000


Identification of a Met-Binding Peptide from a Phage Display Library
journal, October 2007


A target-unrelated peptide in an M13 phage display library traced to an advantageous mutation in the gene II ribosome-binding site
journal, February 2008


Protein nanoparticles as drug carriers in clinical medicine
journal, May 2008


Nanoparticle Assembly of Mesoporous AlOOH (Boehmite)
journal, January 2003


Drug delivery: One nanoparticle, one kill
journal, May 2011


Autoantibodies to Tumor-Associated Antigens in Epithelial Ovarian Carcinoma
journal, January 2009


Biosensors based on release of compounds upon disruption of lipid bilayers supported on porous microspheres
journal, June 2008


Synthetic Protocells Interact with Viral Nanomachinery and Inactivate Pathogenic Human Virus
journal, March 2011


Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers
journal, August 2008


An overview of lipid membrane supported by colloidal particles
journal, May 2007


Epithelial Cell Migration in Response to Epidermal Growth Factor
book, December 2005


Delivery of Ricin Toxin A-Chain by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid Bilayers
journal, April 2012


Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord
journal, June 2013